etrials signs three-year contract with YM

According to etrials, QuickStudy Suite is designed to simplify data collection and speed the clinical research process.

By Editor on Aug 13, 2002

According to etrials, QuickStudy Suite is designed to simplify data collection and speed the clinical research process.

Under the terms of the agreement, etrials' QuickStudy Suite will be used in a variety of clinical trials sponsored by YM BioSciences. YM BioSciences said it will initially deploy etrials' QuickStudy Capture 4.0 component to enable it to more effectively enter, analyze and process critical patient data. The technology will be used in a multi-site, Phase I clinical study of a drug to treat hormone-dependent prostate cancer in male patients. QuickStudy Capture is designed to mirror paper-based case report forms, and, according to etrials, enables site coordinators to capture patient history, assess current health and record adverse events faster and with more accuracy than paper-based systems. QuickStudy Capture also is designed to provide accuracy of recorded data through data checks with etrials' CompiledCheck technology. QuickStudy Capture also includes the ability to move collected data into Oracle Clinical Databases.

"etrials' QuickStudy EDC technology provides our Company with demonstrably quicker access to clinical data, making our clinical development more efficient," said Sean Thompson, Director of Clinical Research, YM BioSciences. "etrials also helps us lower our operating costs by helping to ensure that data collection errors don't occur. In turn, this saves us time and money better spent examining our clinical results rather than backtracking to correct data entries."

"It is rewarding for us to see EDC successfully implemented--and at costs that make sense--even in therapeutic areas such as early oncology studies," said John Cline, President, etrials. "Progressive bio-pharmaceutical companies such as YM BioSciences recognize that etrials offers the best support services and fastest solution deployment time in the business, so that promising clinical research can be analyzed more quickly and more accurately."